Literature DB >> 3500816

High prevalence of antibodies to histones among patients with primary biliary cirrhosis.

E Penner1, S Muller, D Zimmermann, M H Van Regenmortel.   

Abstract

Histones are small, basic proteins involved in the packing of DNA into the eucaryotic nucleus. Using an immunodot assay and an enzyme-linked immunosorbent assay (ELISA), sera from patients with liver disease were tested for antibodies to the five individual histones H1, H2A, H2B, H3 and H4. Histones extracted from calf thymus and separated into individual fractions by gel exclusion chromatography were either immobilized on nitrocellulose or adsorbed to microtitre plates and the resulting immune complexes examined via a streptavidin-biotin bridge. Of the liver disease sera tested, only specimens obtained from primary biliary cirrhosis patients contained antibodies reactive with histones. The predominant reactivity was to histone H1 and H2B, and amounted to 74% for IgM antibodies, and 60% for IgG antibodies. Our data indicate that antibodies specific for histones might represent a novel serological marker for primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500816      PMCID: PMC1542228     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  A new procedure for the isolation and fractionation of histones.

Authors:  D R. van der Westhuyzen; C von Holt
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Quantitation of rheumatoid factors by enzyme immunoassay using biotinylated human IgG.

Authors:  M Zrein; G De Marcillac; M H Van Regenmortel
Journal:  J Immunol Methods       Date:  1986-03-13       Impact factor: 2.303

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

Review 5.  The folding of chromatin.

Authors:  P J Butler
Journal:  CRC Crit Rev Biochem       Date:  1983

Review 6.  Drug-induced lupus: clinical and serological studies.

Authors:  C E Harmon; J P Portanova
Journal:  Clin Rheum Dis       Date:  1982-04

Review 7.  Nucleosome structure.

Authors:  J D McGhee; G Felsenfeld
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.

Authors:  J A Hardin; J O Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Nuclear antigens recognized by antibodies present in liver disease sera.

Authors:  E Penner; I Kindas-Mügge; E Hitchman; G Sauermann
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

10.  Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA).

Authors:  C Kendall; I Ionescu-Matiu; G R Dreesman
Journal:  J Immunol Methods       Date:  1983-02-11       Impact factor: 2.303

View more
  4 in total

Review 1.  Nature of autoantigens and autoantibodies in autoimmune hepatitis.

Authors:  M P Manns; K H Meyer zum Büschenfelde
Journal:  Springer Semin Immunopathol       Date:  1990

2.  The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.

Authors:  J C Courvalin; K Lassoued; E Bartnik; G Blobel; R W Wozniak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.

Authors:  R E Nickowitz; H J Worman
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

4.  Antihistone Autoantibodies in Dobermans With Hepatitis.

Authors:  H Dyggve; S Meri; T Spillmann; H Jarva; M Speeti
Journal:  J Vet Intern Med       Date:  2017-09-30       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.